Low Dose Computed Tomography for Lung Cancer Screening

Study summary

This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an evidence-based intervention comprised of a web-based program and integrated text messaging. The goal is to provide actionable findings about how to most effectively and cost efficiently promote abstinence in LDCT clinics.

Ask AI to explain this study

Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedUsual Care and WEB+TXT

Plus 1 other study approaches.

Who it may be forSmoking

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 29, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Mayo Clinic

Study sponsor

Study overview

What this study is about

Purpose: Treatment
Study type: Interventional
Phase: Not applicable
Sponsor: Mayo Clinic
Interventions being studied: Behavioral: Usual Care; Behavioral: WEB+TXT; Behavioral: WEB+TXT+TTS

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Scheduled for LDCT screening 2. Current smoking (every day/some days) 3. At least weekly use of the Internet 4. Current ownership of cell phone with a text messaging plan 5. Willing to receive study text messages. 6. Ability to complete all aspects of the study 7. Ability to provide signed informed consent

Reasons someone may not be able to joinExclusion criteria

1. Current (in the past 30 days) use of tobacco cessation medication or participation in tobacco cessation treatment. 2. Those with a condition deemed by the investigators to be exclusionary to the study

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Mayo ClinicRochester, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 29, 2019. Always confirm current availability with the study team.

View original record ↗